Insider · CIK 0001617236
Mark S. Levine
Files at IMVT (Immunovant, Inc.). First filing Oct 18, 2024, latest Nov 22, 2024.
Mark S. Levine files SEC Form 4 as officer at IMVT (Immunovant, Inc.). Since Oct 18, 2024, Mark S. Levine has reported 0 open-market buys worth $0 and 3 open-market sells worth $304k, the latest filed on Nov 22, 2024.
A track record needs three past buys with six months of prices behind them; Mark S. Levine has 0, so none is measured yet.
The newest scored trade: sold $93k of IMVT on Nov 20, 2024, filed Nov 22, 2024, scored 40 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IMVT: Immunovant, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | Immunovant, Inc. | $93k 3,650 shares | -1% | - | |
| 41Moderate | Immunovant, Inc. | $129k 4,361 shares | -1% | - | |
| 39Weak | Immunovant, Inc. | $82k 2,860 shares | -1% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 14, 2025 | IMVT IMMUNOVANT, INC. | 69,763 0.04% of outstanding | $1.4M | Feb 14, 2025 | $663k |
| Feb 11, 2025 | IMVT IMMUNOVANT, INC. | 29,196 0.02% of outstanding | $570k | Feb 11, 2025 | $93k |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 20, 2024 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -3,650 | $25.45 | $93k | 319,228 | Nov 22, 2024 |
| Oct 23, 2024 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -4,361 | $29.53 | $129k | 322,878 | Oct 25, 2024 |
| Oct 16, 2024 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -2,860 | $28.79 | $82k | 327,239 | Oct 18, 2024 |
Questions about Mark S. Levine
Answered from the filings on this page, as of the latest one.
Is Mark S. Levine buying or selling?
Not in the last 12 months. Mark S. Levine's latest open-market trade on SEC Form 4 was sold $93k of IMVT on Nov 20, 2024.
How did Mark S. Levine's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark S. Levine has 0.
Where does Mark S. Levine file Form 4?
Mark S. Levine has filed Form 4 at IMVT (Immunovant, Inc.) as Chief Legal Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.